NCT05382988View on ClinicalTrials.gov

Sodium Zirconium Cyclosilicate Lowers Hyperkalemia After Parathyroidectomy

PHASE3CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Sodium Zirconium CyclosilicateHyperkalemiaHyperparathyroidism, Secondary
Interventions
DRUG

Sodium zirconium cyclosilicate

The experimental group was required to take SZC 10g at 6 am on the day of surgery.

All Listed Sponsors
lead

Guangdong Provincial People's Hospital

OTHER

NCT05382988 - Sodium Zirconium Cyclosilicate Lowers Hyperkalemia After Parathyroidectomy | Biotech Hunter | Biotech Hunter